Kovitz Investment Group Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,600
Closed -$63.3K 502
2025
Q3
$63.3K Hold
13,600
﹤0.01% 1382
2025
Q2
$134K Hold
13,600
﹤0.01% 1310
2025
Q1
$90.8K Hold
13,600
﹤0.01% 1215
2024
Q4
$149K Buy
+13,600
New +$4.04M ﹤0.01% 1190

Other funds holding AMGN

Kovitz Investment Group Partners's AMGN Position: Q1 2026 in Review

Kovitz Investment Group Partners reduced its Amgen (AMGN) stake by 2.1% in Q1 2026, selling an estimated $26.4K and leaving 3,373 shares worth $1.19M. The position accounts for 0.03% of the portfolio, ranked #299.

Kovitz Investment Group Partners first reported a position in AMGN in Q1 2016 and has held it in 41 quarters since. The position peaked at $29.3M in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Kovitz Investment Group Partners held 3,373 shares of Amgen worth $1.19M as of Q1 2026.
  • Kovitz Investment Group Partners sold 74 Amgen shares in Q1 2026, an estimated $26.4K.
  • Amgen made up 0.03% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #299 holding.
  • Kovitz Investment Group Partners first reported a position in Amgen in Q1 2016 and has held it in 41 quarters since.
  • Kovitz Investment Group Partners's Amgen position peaked at $29.3M in Q1 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.